BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22743837)

  • 1. Surveillance of Childhood Cancer Survivors: A Lifelong Affair.
    Applebaum MA; Cohn SL
    J Clin Oncol; 2015 Nov; 33(31):3531-2. PubMed ID: 26261248
    [No Abstract]   [Full Text] [Related]  

  • 2. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
    Darrington DL; Vose JM
    Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late complications after treatment for Hodgkin lymphoma.
    Ng AK
    Curr Hematol Malig Rep; 2008 Jul; 3(3):119-25. PubMed ID: 20425456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma.
    Travis LB
    Hematology Am Soc Hematol Educ Program; 2007; ():192-6. PubMed ID: 18024629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors.
    Wong SM
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101525. PubMed ID: 38092481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors.
    Bakkach J; Pellegrino B; Elghazawy H; Novosad O; Agrawal S; Bennani Mechita M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103175. PubMed ID: 33321295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    J Thorac Dis; 2012 Feb; 4(1):22-9. PubMed ID: 22295164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent ischemia: clinical relevance.
    Conti CR; Bavry AA; Petersen JW
    J Am Coll Cardiol; 2012 Jan; 59(5):435-41. PubMed ID: 22281245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects in the era of modern therapy for Hodgkin lymphoma.
    Hodgson DC
    Hematology Am Soc Hematol Educ Program; 2011; 2011():323-9. PubMed ID: 22160053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome.
    Schoenfeld JD; Mauch PM; Das P; Silver B; Marcus KJ; Stevenson MA; Ng AK
    Ann Oncol; 2012 Jul; 23(7):1813-8. PubMed ID: 22104573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma.
    Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Bello CM; Bierman PJ; Blum KA; Dabaja B; Duron Y; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Maloney DG; Mansur D; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Poppe M; Pro B; Weiss L; Winter JN; Yahalom J;
    J Natl Compr Canc Netw; 2011 Sep; 9(9):1020-58. PubMed ID: 21917626
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue Doppler evaluation of systolic and diastolic cardiac functions in long-term survivors of Hodgkin lymphoma.
    Alehan D; Sahin M; Varan A; Yıldırım I; Küpeli S; Büyükpamukçu M
    Pediatr Blood Cancer; 2012 Feb; 58(2):250-5. PubMed ID: 21850678
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.